1. Immunotherapy of bladder cancer;Alexandroff,2000
2. C. CPG 7909, a TLR9 agonist, added to first line taxane/platinum for advanced non-small cell lung cancer, a randomized, controlled phase II study;Leichman,2005
3. A sweeter future for imino sugars.;Carroll,2005
4. Therapeutic cancer vaccines: at midway between immunology and pharmacology;Lage;Curr. Cancer Drug Targets,2005
5. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials;Mosolits;Exp. Rev. Vaccines,2005